|
Volumn 38, Issue 5, 2001, Pages
|
The UKPDS: Implications for the dyslipidaemic patient
|
Author keywords
Diabetes; Dyslipidaemia; Lipids; UKPDS
|
Indexed keywords
ATORVASTATIN;
PLACEBO;
ADULT;
AGED;
ATHEROGENESIS;
BODY WEIGHT;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
COMORBIDITY;
CONFERENCE PAPER;
DYSLIPIDEMIA;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
LIPID BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MICROVASCULATURE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
SECONDARY PREVENTION;
ANTILIPEMIC AGENTS;
CLINICAL TRIALS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPERLIPIDEMIAS;
HYPOGLYCEMIC AGENTS;
|
EID: 0035674460
PISSN: 09405429
EISSN: None
Source Type: Journal
DOI: 10.1007/s005920170003 Document Type: Conference Paper |
Times cited : (17)
|
References (17)
|